Sana Biotechnology inks $50M deal for precise gene editing system from Beam Therapeutics
GeekWire
OCTOBER 19, 2021
Sana Biotechnology has a new $50 million tool in its toolbox. Beam may also receive additional payments, for instance upon the achievement of development and sales milestones. Sana aims to develop therapeutics for conditions as diverse as cancer, diabetes and cardiovascular disorders. Sana CEO and president Steve Harr.
Let's personalize your content